Heimer et al. demonstrate in a preclinical study that a #TantalumOxide–based nanoparticle #ContrastAgent showed higher hepatic contrast enhancement and improved the detection of #HepaticTumors in #ComputedTomography. #UCSFimaging #LMUradiology
doi.org/10.1097/rli....
doi.org/10.1097/rli....
March 26, 2025 at 8:19 AM
Heimer et al. demonstrate in a preclinical study that a #TantalumOxide–based nanoparticle #ContrastAgent showed higher hepatic contrast enhancement and improved the detection of #HepaticTumors in #ComputedTomography. #UCSFimaging #LMUradiology
doi.org/10.1097/rli....
doi.org/10.1097/rli....
Heimer at al. show that a novel intravenous #Tantalum oxide nanoparticle #ContrastAgent provides contrast advantages compared to #Iopamidol for improved visualization of thoracic arteries and veins in a multiphase #CT protocol. #LMUradiology #UCSFimaging
t.co/cNCylQophB
t.co/cNCylQophB
December 4, 2024 at 8:10 PM
Heimer at al. show that a novel intravenous #Tantalum oxide nanoparticle #ContrastAgent provides contrast advantages compared to #Iopamidol for improved visualization of thoracic arteries and veins in a multiphase #CT protocol. #LMUradiology #UCSFimaging
t.co/cNCylQophB
t.co/cNCylQophB
The European Society of #Urogenital #Radiology has updated its practice guidelines on management of hypersensitivity reactions to contrast media. Go to our report: buff.ly/W0pH3Fq #ContrastAgent
ESUR updates advice on hypersensitivity reactions to contrast media
The European Society of Urogenital Radiology (ESUR) has updated its guidelines on the management of hypersensitivity reactions to contrast media.
buff.ly
June 2, 2025 at 12:15 PM
The European Society of #Urogenital #Radiology has updated its practice guidelines on management of hypersensitivity reactions to contrast media. Go to our report: buff.ly/W0pH3Fq #ContrastAgent
🦠🔦 A new, #bacteria-based contrast agent illuminates #tumors like a neon sign during #surgery, enabling more precise resection and reducing the risk of recurrence. #contrastagent http://dlvr.it/TM73Ts
July 26, 2025 at 6:30 AM
🦠🔦 A new, #bacteria-based contrast agent illuminates #tumors like a neon sign during #surgery, enabling more precise resection and reducing the risk of recurrence. #contrastagent http://dlvr.it/TM73Ts
Did you know that MRI scans can sometimes leave traces of toxic metals in the body? Recent research shows that gadolinium, a metal used in MRI contrast agents
#MRI #Healthcare #PatientSafety #Radiology #MedicalResearch #Gadolinium #ContrastAgent #HealthAwareness
#MRI #Healthcare #PatientSafety #Radiology #MedicalResearch #Gadolinium #ContrastAgent #HealthAwareness
April 23, 2025 at 12:21 AM
Did you know that MRI scans can sometimes leave traces of toxic metals in the body? Recent research shows that gadolinium, a metal used in MRI contrast agents
#MRI #Healthcare #PatientSafety #Radiology #MedicalResearch #Gadolinium #ContrastAgent #HealthAwareness
#MRI #Healthcare #PatientSafety #Radiology #MedicalResearch #Gadolinium #ContrastAgent #HealthAwareness
Researchers led by 🇨🇿 @iocbprague.bsky.social, with 🇩🇪 @unituebingen.bsky.social have developed a new type of #contrastagent for use in both #MRI and #PET imaging has the potential to significantly enhance diagnosis and subsequent treatment, particularly for #kidney diseases and tumors.
New dual PET/MRI contrast agent to enhance kidney diagnostics
A research team from IOCB Prague, working in collaboration with the University of Tübingen, Germany, and the Faculty of Science, Charles University, has developed a new type of contrast agent that can be used in both magnetic resonance imaging (MRI) and positron emission tomography (PET).
dlvr.it
August 9, 2024 at 6:30 AM
Researchers led by 🇨🇿 @iocbprague.bsky.social, with 🇩🇪 @unituebingen.bsky.social have developed a new type of #contrastagent for use in both #MRI and #PET imaging has the potential to significantly enhance diagnosis and subsequent treatment, particularly for #kidney diseases and tumors.
Scientists @leibnizFMP led by Leif Schröder demonstrate new contrast agent for early diagnosis of brain metastases, using synthetic molecule that helps to detect the formation of new blood vessels for more sophisticated imaging https://t.co/Dl3NqvtuiH #contrastagent #imaging
February 6, 2025 at 2:19 PM
Scientists @leibnizFMP led by Leif Schröder demonstrate new contrast agent for early diagnosis of brain metastases, using synthetic molecule that helps to detect the formation of new blood vessels for more sophisticated imaging https://t.co/Dl3NqvtuiH #contrastagent #imaging